The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-Ethylsulfanyl-3-methyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole ID: ALA264214
Cas Number: 99499-40-8
PubChem CID: 65861
Max Phase: Phase
Molecular Formula: C16H17N3OS2
Molecular Weight: 331.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: Disuprazole | Disuprazole|Disuprazole [INN]|99499-40-8|V81J4OO2OT|CHEMBL264214|Disuprazolum|Disuprozol|2-(((4-(Ethylthio)-3-methyl-2-pyridyl)methyl)sulfinyl)benzimidazole|Disuprazolum [Latin]|Disuprozol [Spanish]|UNII-V81J4OO2OT|Disuprazole, 99%|SCHEMBL1815548|DTXSID60869337|BDBM50009041|2-[(4-ethylsulfanyl-3-methylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole|NS00127072|Q27291649|2-(4-Ethylsulfanyl-3-methyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole|2-{[4-(Ethylsulfanyl)-3-methylpyridin-2-y Show More⌵
Canonical SMILES: CCSc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C
Standard InChI: InChI=1S/C16H17N3OS2/c1-3-21-15-8-9-17-14(11(15)2)10-22(20)16-18-12-6-4-5-7-13(12)19-16/h4-9H,3,10H2,1-2H3,(H,18,19)
Standard InChI Key: YWQUFKJVMWHDSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
10.4329 -9.0385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5209 -9.8608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1870 -8.6988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7130 -8.6257 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.2845 -8.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0045 -9.0419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5761 -9.0454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3369 -10.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7496 -9.3176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2899 -7.8100 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8604 -8.6352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7141 -7.8041 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1478 -9.0489 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.5856 -7.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8573 -7.8111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5793 -9.8695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7506 -10.7502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5760 -9.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4320 -8.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7193 -9.0525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9874 -10.0272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5748 -10.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 6 1 0
6 4 1 0
7 5 2 0
8 2 1 0
9 3 1 0
10 5 1 0
11 7 1 0
12 4 1 0
13 11 1 0
14 10 2 0
15 14 1 0
16 7 1 0
17 8 2 0
18 9 2 0
19 13 1 0
20 19 1 0
21 18 1 0
22 17 1 0
8 9 1 0
22 21 2 0
15 11 2 0
M CHG 2 4 1 12 -1
M END
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 331.47Molecular Weight (Monoisotopic): 331.0813AlogP: 3.69#Rotatable Bonds: 5Polar Surface Area: 64.63Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.35CX Basic pKa: 2.86CX LogP: 3.12CX LogD: 3.11Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.57Np Likeness Score: -0.97
References 1. Sih JC, Im WB, Robert A, Graber DR, Blakeman DP.. (1991) Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors., 34 (3): [PMID:1848293 ] [10.1021/jm00107a026 ] 2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date,